Related Experiment Video
Updated: Apr 28, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Hydrogen sulfide represses androgen receptor transactivation by targeting at the second zinc finger module
Abstract:
Androgen receptor (AR) signaling is indispensable for the development of prostate cancer from the initial androgen-dependent state to a later aggressive androgen-resistant state. This study examined the role of hydrogen sulfide (H(2)S), a novel gasotransmitter, in the regulation of AR signaling as well as its mediation in androgen-independent cell growth in prostate cancer cells. Here we found that H(2)S inhibits cell proliferation of both androgen-dependent (LNCaP) and antiandrogen-resistant prostate cancer cells (LNCaP-B), with more significance on the latter, which was established by long term treatment of parental LNCaP cells with bicalutamide. The expression of cystathionine γ-lyase (CSE), a major H(2)S producing enzyme in prostate tissue, was reduced in both human prostate cancer tissues and LNCaP-B cells. LNCaP-B cells were resistant to bicalutamide-induced cell growth inhibition, and CSE overexpression could rebuild the sensitivity of LNCaP-B cells to bicalutamide. H(2)S significantly repressed the expression of prostate-specific antigen (PSA) and TMPRSS2, two AR-targeted genes. In addition, H(2)S inhibited AR binding with PSA promoter and androgen-responsive element (ARE) luciferase activity. We further found that AR is post-translationally modified by H(2)S through S-sulfhydration. Mutation of cysteine 611 and cysteine 614 in the second zinc finger module of AR-DNA binding domain diminished the effects of H(2)S on AR S-sulfhydration and AR dimerization. These data suggest that reduced CSE/H2S signaling contributes to antiandrogen-resistant status, and sufficient level of H(2)S is able to inhibit AR transactivation and treat castration-resistant prostate cancer.
Insights
Hydrogen sulfide (H2S) inhibits prostate cancer cell growth, particularly in antiandrogen-resistant cells. Reduced H2S production is linked to resistance, suggesting H2S as a potential therapy for castration-resistant prostate cancer.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Androgen receptor (AR) signaling drives prostate cancer progression.
- Therapeutic resistance, particularly antiandrogen resistance, remains a major clinical challenge.
- Hydrogen sulfide (H2S), a gasotransmitter, has emerging roles in cellular regulation.
Purpose of the Study:
- To investigate the role of H2S in regulating AR signaling.
- To determine H2S's effect on androgen-independent prostate cancer cell growth.
- To explore H2S as a potential therapeutic agent for castration-resistant prostate cancer.
Main Methods:
- Cell proliferation assays in androgen-dependent and resistant prostate cancer cell lines.
- Analysis of cystathionine γ-lyase (CSE) expression in prostate cancer tissues and cells.
- Gene expression analysis of AR-targeted genes (PSA, TMPRSS2).
- Assays for AR binding to PSA promoter and androgen-responsive element (ARE) luciferase activity.
- Investigation of AR post-translational modification (S-sulfhydration) and its impact on AR dimerization.
Main Results:
- H2S inhibited proliferation in both androgen-dependent and antiandrogen-resistant prostate cancer cells.
- Reduced CSE expression, a key H2S-producing enzyme, was observed in resistant cells and human prostate cancer tissues.
- Overexpression of CSE restored sensitivity to antiandrogen treatment in resistant cells.
- H2S repressed AR-targeted gene expression (PSA, TMPRSS2) and inhibited AR binding to the PSA promoter.
- AR was found to be S-sulfhydrated by H2S, affecting AR dimerization and DNA binding.
Conclusions:
- Reduced CSE/H2S signaling contributes to the development of antiandrogen resistance in prostate cancer.
- Sufficient H2S levels can inhibit AR transactivation and AR signaling.
- H2S holds therapeutic potential for treating castration-resistant prostate cancer.
More Related Videos
Related Concept Videos
Co-activators and Co-repressors
Hedgehog Signaling Pathway
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Preparation and Reactions of Sulfides
Intracellular Hormone Receptors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

